John Ackerman sold $26M of GRDN
director at Guardian Pharmacy Services, Inc.. 1,285,579 shares at an average of $20.16, traded May 27, 2025, filed May 29, 2025.
Score components
- +15RoleDirector
- +25Trade size$25.9M at market
- +20Share of holdings soldSold 91% of holdings
- +15Cluster9 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -0.0%, 3m +22.3%, 6m +37.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-078971, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 27, 2025 | SOpen-market sale Class A Common Stockindirect: By Pharmacy Investors, LLC | -813,318 | $20.16 | $16M | 600,622 | May 29, 2025 |
| May 27, 2025 | SOpen-market sale Class A Common Stockindirect: By Cardinal Equity Fund, L.P. | -270,958 | $20.16 | $5.5M | 200,099 | May 29, 2025 |
| May 28, 2025 | SOpen-market sale Class A Common Stockindirect: By Pharmacy Investors, LLC | -150,998 | $20.16 | $3.0M | 449,624 | May 29, 2025 |
| May 28, 2025 | SOpen-market sale Class A Common Stockindirect: By Cardinal Equity Fund, L.P. | -50,305 | $20.16 | $1.0M | 149,794 | May 29, 2025 |
Related signals
Other insiders at Guardian Pharmacy Services, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 75Notable | Guardian Pharmacy Services, Inc. | John Ackerman director | $33M 1,103,364 shares | -59% | |
| 65Notable | Guardian Pharmacy Services, Inc. | William E Bindley director, owner | $106M 3,570,677 shares | -44% | |
| 62Notable | Guardian Pharmacy Services, Inc. | Bindley Capital Partners I, LLC owner | $106M 3,570,677 shares | -44% | |
| 65Notable | Guardian Pharmacy Services, Inc. | Fred Burke See Remarks | $20M 671,432 shares | -44% | |
| 58Moderate | Guardian Pharmacy Services, Inc. | Cardinal Equity Fund, L.P. other | $8.2M 275,728 shares | -44% | |
| 65Notable | Guardian Pharmacy Services, Inc. | Kendall Forbes See Remarks | $10M 346,672 shares | -43% | |
| 65Notable | Guardian Pharmacy Services, Inc. | Thomas J Salentine Jr director, owner | $106M 3,570,677 shares | -44% | |
| 58Moderate | Guardian Pharmacy Services, Inc. | Pharmacy Investors, LLC other | $25M 827,636 shares | -44% | |
| 65Notable | Guardian Pharmacy Services, Inc. | David K Morris See Remarks | $5.6M 187,855 shares | -42% | |
| 28Weak | GRDNbuy Guardian Pharmacy Services, Inc. | Steven D Cosler director | $100k 3,370 shares | +16% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.